Current Status in India

Zika virus, a mosquito-borne flavivirus, has been a public health concern in India since its re-emergence in 2017. The first confirmed case in Rajasthan was reported in September 2018, followed by sporadic cases in Gujarat, Tamil Nadu, and other states. As of 2026, India has implemented robust surveillance and diagnostic protocols to manage outbreaks effectively.

Historically, the virus was first isolated in India in 1952-53 during a serological survey in Pune. Since then, periodic cases have been reported, but large-scale outbreaks have been limited. The Indian Council of Medical Research (ICMR) and state health departments continue to monitor and respond to potential threats.

Transmission Vectors and Incubation

Zika virus is primarily transmitted through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. These mosquitoes are widespread in India, especially during monsoon and post-monsoon seasons. The incubation period typically ranges from 3 to 14 days after the bite.

In addition to vector-borne transmission, the virus can spread through:

• Sexual contact (including vaginal, anal, and oral sex)
• Blood transfusion (rare but documented)
• Mother-to-fetus transmission during pregnancy

Symptoms and Clinical Presentation

Most Zika virus infections (approximately 80%) are asymptomatic. When symptoms do occur, they are generally mild and last for 2-7 days. Common symptoms include:

• Fever (usually low-grade)
• Maculopapular rash
• Joint pain (especially in small joints of hands and feet)
• Conjunctivitis (red eyes)
• Muscle pain and headache

Severe complications are rare but can include Guillain-Barré syndrome and, in pregnant women, congenital Zika syndrome leading to microcephaly and other neurological defects in the fetus.

Diagnosis and Testing

Accurate diagnosis is crucial for patient management and public health response. DNA Labs India offers molecular and serological tests for Zika virus detection.

Molecular Testing (RT-PCR)

Reverse Transcription-Polymerase Chain Reaction (RT-PCR) is the preferred method for detecting active infection. It is most effective when performed within the first 7 days of symptom onset. The test detects viral RNA in blood, urine, or saliva.

Serological Testing (IgM/IgG)

Serology detects antibodies produced by the immune system. IgM antibodies appear around day 4-5 and can persist for up to 12 weeks. IgG antibodies develop later and indicate past infection. Cross-reactivity with other flaviviruses (e.g., dengue) is a limitation, so results must be interpreted carefully.

Sample Requirements and Turnaround Time

For RT-PCR, a blood sample (serum or plasma) is required. No fasting is necessary. The turnaround time is typically 2-3 business days. For serology, a similar blood sample is used, with results available in 3-5 days.

Cost: [Insert Current 2026 Price] – please contact DNA Labs India for the latest pricing.

Information Gain Table: Symptom Timeline

Prevention and Control

Prevention focuses on reducing mosquito exposure and interrupting transmission. Key measures include:

• Using EPA-approved insect repellents
• Wearing long-sleeved clothing and pants
• Using mosquito nets, especially during daytime rest
• Eliminating standing water where mosquitoes breed
• Installing window and door screens

For sexual transmission prevention, WHO recommends consistent use of condoms or abstinence for at least 3 months after exposure for men and 2 months for women, especially if pregnant or planning pregnancy.

Zika Virus in Major Indian Cities

The following is a summary of historical and current status:

• Jaipur (Rajasthan): First confirmed case in September 2018; subsequent surveillance identified additional cases.
• Ahmedabad (Gujarat): Cases reported in 2017-2018, including a pregnant woman.
• Hyderabad, Bangalore, Mumbai, Delhi, Kolkata, Chennai: No confirmed indigenous cases as of 2026; sporadic suspected cases have been ruled out by testing.

It is essential to note that the epidemiological situation is dynamic. DNA Labs India provides reliable testing across all major cities to support early detection and containment.

Why Choose DNA Labs India?

DNA Labs India is an ISO 9001 certified laboratory with state-of-the-art molecular diagnostics. Our Zika virus testing is performed using validated RT-PCR protocols, ensuring accurate and timely results. We follow strict quality control measures and adhere to national guidelines.

For appointments and sample collection, contact our customer support or visit our website.